marketing, digital, investor, investor communications, PR
Get in Touch

Content Carnivores Heads to JPM Healthcare Conference with Prestigious Clients and Insights into 2024 Healthcare Landscape

Leaders in pharma, biotech, and medtech converge in San Francisco January 7-11, 2024
Key Takeaways
  • Heading into 2024, healthcare leaders face competing headwinds as they seek to drive results and prove their value to investors. With share prices and investments significantly down, the importance of factual, relevant information is critical.
  • Keeping a compelling narrative in front of investors, partners and stakeholders has proven to be the most cost-effective way to communicate the company's vision and reason-to-believe.
  • In tough times, the often over-priced and ineffectual tactics of traditional IR, PR and Marcom have given rise to best practices perfected in B2C digital marketing, and deployed by Content Carnivores

Chicago, IL. and Park City, UT January 7, 2024- Content Carnivores â€“ a leading life science marketing and communications agency, is heading to the prestigious J.P. Morgan Healthcare Conference in San Francisco this week (January 7-11) with a strong presence representing multiple clients and sharing keen insights into the 2024 biotec landscape.

Industry Veterans Leading the Charge:

Founder Jeffrey Walker and VP of Customer Success/Partner Chelli Miller will be representing Content Carnivores, leveraging their extensive experience to support clients who are presenting at the conference and each moderating non-client company presentations at Biotech Showcase. Their presence further signifies Content Carnivores' commitment to driving thought leadership within the healthcare industry.

Clients Taking Center Stage:

Content Carnivores is proud to support several clients who will be present at the conferences during JPM Week, including:

  • GeoVax Labs ($GOVX): This innovative biotech company boasts fully enrolled trials for cancer and infectious disease products, scientific articles in prestigious vaccine publications, and pandemic-ready manufacturing capacity, making it a strong contender in the current market. Geovax CEO David Dodd will be presenting at Biotech Showcase on Monday, January 8th at 2:30 pm PST.
  • AVITA Medical ($RCEL): This commercial-stage regenerative medicine company will be presenting its RECELL® System, a transformative solution for skin restoration. Avita CEO Jim Corbett will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 11:15 a.m. Pacific Time.
  • Pacylex Pharmaceuticals: This exciting company with its first-in-class therapy, zelenirstat, presents a compelling investment opportunity in the oncology space. Zelenirstat targets a novel pathway, potentially surpassing existing treatments in both efficacy and tolerability. Pacylex CEO, Michael Weickert, is raising a Series B financing and available to connect through the BIO partnering system.
  • BioUtah: Representing the dynamic life sciences community in Utah, BioUtah CEO Kelvyn Cullimore will be on hand to discuss and promote the state's business-friendly environment and growing life sciences ecosystem.

Next stop after the JPM Week? The 2024 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit. Presented by BioUtah and the University of Utah Technology Licensing Office, March 14-15, 2024. The Park City office of Content Carnivores will be sponsoring this event for the 3rd year.

Navigating the 2024 Healthcare Landscape:

Beyond client support, Content Carnivores is bringing valuable insights to the conference, gleaned from their close work with healthcare leaders. They anticipate key trends such as:

  • Increased M&A Activity: With many companies with genius in their pipeline and diminished runway, no doubt that mergers and acquisitions will rise in oncology, immunology, and cardiovascular diseases. Now's the time for such companies to broadcast their science, build their brand, and increase their value beyond just the balance sheet.
  • Hype around potential IPO Boom. It was a slow 2023, and the bankers would love to see IPO activity increase. That would mean companies would need to find the resources to fund an IPO and hope that investors with cash would opt-in. Let's see what premieres during JPM Week.

Connecting and Collaborating:

The J.P. Morgan Healthcare Conference provides a prime opportunity for Content Carnivores to connect with investors, partners, and industry leaders. They look forward to fostering collaboration and driving success for their clients amidst the dynamic 2024 healthcare landscape.

Content Carnivores is a leading healthcare marketing agency specializing in helping B2B healthcare companies achieve their full potential. They leverage their deep industry knowledge, creative storytelling, and proven strategies to deliver impactful results for their clients.

Connect with Content Carnivores at JPM:

To learn more about Content Carnivores and their clients at the J.P. Morgan Healthcare Conference, please reach out to them directly.

Chelli@ContentCarnivores.com



ABOUT CONTENT CARNIVORES, LLC
Content Carnivores is dedicated to delivering the highest standards of ideas and writing so that greatness finds its widest audience to deliver on business objectives. Headquartered in Chicago with an office in Park City, Utah, they leverage proprietary technology that dramatically speeds up the discovery, creation, and publication of high-quality content to help brands and businesses amplify awareness and establish thought leadership to their target audiences.

The company founders have run innovative content marketing and advertising programs for global marketing pioneers. Current clients include leaders in healthcare, marketing, medical devices, financial services, and technology.


Key Takeaways
  • Heading into 2024, healthcare leaders face competing headwinds as they seek to drive results and prove their value to investors. With share prices and investments significantly down, the importance of factual, relevant information is critical.
  • Keeping a compelling narrative in front of investors, partners and stakeholders has proven to be the most cost-effective way to communicate the company's vision and reason-to-believe.
  • In tough times, the often over-priced and ineffectual tactics of traditional IR, PR and Marcom have given rise to best practices perfected in B2C digital marketing, and deployed by Content Carnivores
Media Gallery
Quotes
Being part of this breakthrough science is a highlight of our year.
Jeffrey WalkerFounder and CEO
Related Bios
Jeffrey Walker
Founder and CEO
View Full Bio>>
Chelli Miller
Partner and Iron Chef
View Full Bio>>
Contacts
Chelli Miller
chelli@contentcarnivores.com
219-921-6823